The global central venous catheter market is on a strong upward trajectory, with projections indicating a rise from USD 2,861.0 million in 2024 to a remarkable USD 5,436.8 million by 2034. This growth ...

Many American doctors and scientists are looking to work in Canada as U.S. health programs get cut and mass layoffs sweep the ...

For use in clearing occlusions of venous-access devices ... and 2 mg to clear clots in central venous catheters pending the results of a study to determine the effectiveness of smaller doses.

the agreement grants Vizient’s members access to Teleflex’s Central Venous Access Catheters and Arterial Catheters under pre-negotiated terms, enhancing cost-efficiency and care quality for ...

Healthcare systems face challenges in meeting the growing demand for dialysis services due to critical gaps and shortcomings.

CorMedix ( CRMD 1.02%) Q4 2024 Earnings Call Mar 25, 2025, 8:30 a.m. ET Good day, and welcome to the CorMedix Inc. fourth-quarter and full-year 2024 financial results conference call. All participants ...

CASCADE, Central venous Access device SeCurement And Dressing Effectiveness; PICC, Peripherally inserted central catheter; nt, non-tunnelled; t, tunnelled. Sample size estimates: A reduction in ...

Vascular access devices (VADs), the most common type of invasive ... 46.7% of hospitalised patients have a PIVC and 7.5% have a central venous catheter (CVC).2 Many government organisations and public ...

Eligible oncology patients can receive their oral cancer medications at home while being treated for other medical needs ...

The Trump administration has pressed forwards with plans to unleash a wave of trillions in public spending cuts ...

Li, C.T., Qian, Z., Wang, Y.Q.,Long, X.Q. andMao,H.M. (2025) Advances in the Study of Venous Thrombosis Associated with Peripherally Inserted Central Venous Catheters. Journal of Biosciences and ...

Doctors and scientists are eyeing Canada as a place to work because of the current American situation. In the United States, ...